DGAP-Adhoc: INDUS Holding AG strengthens its equity base

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 2, 2013 at 3:45 PM

DGAP-Adhoc: INDUS Holding AG strengthens its equity base with successful capital of approx. EUR 60 million

INDUS Holding AG / Key word(s): Capital Increase 02.12.2013 21:36 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- This release and the information announced herein are not to be passed on to the United States of America, Australia, Japan or Canada. Bergisch Gladbach, December 2, 2013. The Board of Management of INDUS Holding AG (ISIN DE0006200108, WKN 620010) today decided, with the consent of the Supervisory Board, to increase the share capital from authorised capital of EUR 57,792,116.42 by EUR 5,779,207.20 to EUR 63,571,323.62 through the issue of 2,222,772 new bearer shares representing EUR 2.60 of the share capital each against cash contribution. The Board of Management has excluded shareholders' subscription right to these new shares with the consent of the Supervisory Board. The new shares are entitled to profits from 1 January 2013. They are to be admitted to trading in the regulated market (Prime Standard) of the Frankfurt Stock Exchange and the DÃ¼sseldorf Stock Exchange without a prospectus. The offering price per share is EUR 27.03; INDUS Holding AG will generate gross proceeds of about EUR 60 Mio. from the capital increase. In the context of a private placement 80% of the new shares were placed with large institutional investors with Versicherungskammer Bayern, as the single most important investor, subscribing some 40% of the new shares to support the company's growth strategy. Another 20% were acquired by other long-term investors and family offices.The transaction was accompanied by Bankhaus Lampe and law firm Osborne Clarke. By strengthening the equity and liquidity base INDUS has laid a stable foundation for the ongoing development of the company and opened up additional opportunities for the acquisition of new investments. In the context of its 'Compass 2020' strategy, INDUS plans further acquisitions for 2014. -------------------------------------------------------------------------- Information and Explanation of the Issuer to this News: This publication does not constitute a public offer of securities in Germany. This publication does not constitute an offer to sell securities, or a solicitation of an offer to buy securities, in the United States of America or in any other jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the 'Securities Act'). The securities of INDUS Holding AG described herein have not been and will not be registered under the Securities Act, or the laws of any State, and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable State laws. INDUS Holding AG does not intend to register any portion of the offering in the United States or conduct a public offering of securities in the United States. Contact: Regina Wolter Corporate Communications & Investor Relations Phone +49 2204 4000 70 E-Mail wolter@indus.de 02.12.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: INDUS Holding AG KÃ¶lner StraÃ?e 32 51429 Bergisch Gladbach Germany Phone: +49 (0)2204 40 00-0 Fax: +49 (0)2204 40 00-20 E-mail: indus@indus.de Internet: www.indus.de ISIN: DE0006200108 WKN: 620010 Listed: Regulierter Markt in DÃ¼sseldorf, Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, MÃ¼nchen, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava's Stock Tumble Sparks Investor Class Action

A Rocky Day for Endava Investors Here's the thing, on September 21, 2026, Endava plc hit a rough patch that left a mark. After the market closed, the company announced that it had put its Chief Financial Officer, Mark Thurston, on administrative leave. This wasn't just a routine shuffle; it came on the heels of the Board's Audit Committee finding reason to probe into...

CorePower Yoga Expands in Miami with New Studios

Greasing the Wheels of Miami's Wellness Scene If you're living under a rock, you might not have noticed, but CorePower Yoga is making some serious moves in Miami. We're talking about two new studios opening their doors: one in Midtown Miami, already rolling out the mats as of October 19, and another flagship joint soon to hit Coral Gables. Clearly, they see the demand for...

Geothermal Energy Gets Boost with GRMS Adoption

Geothermal's Big Leap with the GRMS The oil and gas sector didn't explode overnight—it leapt due to a consistent, standardized language that spoke to investors like a charm. Now, the geothermal industry is borrowing a page from this book of success with the Geothermal Resources Management System (GRMS). Finally, a framework not just built on hope and hot air, but...

Call to Action: Make Disease Cure the Top Election Issue

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

Norwegian Bella™: A New Era in Luxury Cruising

Setting Sail with Norwegian Bella™ in 2028 When you hear about another cruise ship hitting the water, eye rolls might come naturally. But Norwegian Cruise Line's latest announcement adds a few twists worth noting. Today, the big news is that the Norwegian Bella™, the freshest face in NCL's innovative Prima Class, is now open for bookings. This beauty will start its...

NSSF Battles NM's Unconstitutional Gun Law in Court

Taking Shots at New Mexico's Gun Laws You've got the National Shooting Sports Foundation (NSSF) heading back into the legal trenches. Fresh lawsuit filed, they're targeting New Mexico's Attorney General, Raúl Torrez, for trying to keep a seven-day "cooling off" period intact that they've already been told is unconstitutional. Look, this ain't their first rodeo with this...

Zika Virus: A Surprising Ally in Brain Cancer Fight

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

AI Agents Race: 10M Downloads Spark Competitive Fire

The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...

Parents as Teachers Podcast: Anthem Awards Finalist

Celebrating Impact Through Parenthood Narratives Blending heartfelt stories with educational insights, the Parents as Teachers Podcast stands tall as a Finalist in two categories of the 6th Annual Anthem Awards. Recognizing achievements in Content & Media for both Education, Art & Culture and Health, this nod acknowledges the profound impact being made on family...

PrecisePK Celebrates 40 Years of Revolution in Dosing

Forty Years of Changing the Game There’s something to be said for sticking around in an industry for four decades. PrecisePK, a name that's become synonymous with precision dosing, has been revolutionizing how pharmacists do their jobs since 1985. This isn’t just a company resting on its laurels; it’s at the forefront of technological integration in healthcare....